Life Insurance With Cancer
Cancer can often be successfully treated, thanks to significant advances in medical technology and treatment. The life insurance industry recognizes these advances when evaluating applicants with a history of cancer.
A pathology report is one of the most important sources of information insurers use when evaluating cancer history, including the tumor type, stage, and grade.
With access to 50+ life insurance carriers, we know which companies may be more competitive for applicants with specific types and histories of cancer. Our experienced team can help identify carriers whose underwriting guidelines may be a good fit for your individual circumstances and help you explore your coverage options.
Some life insurance carriers have very favorable underwriting guidelines for applicants with a history of prostate cancer.
For example, one carrier may consider an applicant age 60 or older at diagnosis, with a Gleason score of 6 or lower, no evidence of invasion, a pre-treatment PSA below 10, an undetectable post-treatment PSA, and at least 12 months since surgery for preferred rates—assuming the rest of the medical history and underwriting requirements are favorable.
Even applicants with a Gleason score of 7 may have several carrier options available. Certain treatment histories, including seed implants and radiation, may also fit within favorable underwriting guidelines depending on the carrier and individual circumstances.
Underwriting guidelines for prostate and breast cancer have become significantly more flexible over the years. With access to multiple carriers, we can identify companies whose guidelines may be more favorable for your specific history and help you explore your life insurance options.
Many types of cancer may be insurable after a five-year period, depending on the type, severity, treatment, and overall medical history. The treatment received can also play an important role in how an insurance carrier evaluates risk.
A cancer diagnosis does not automatically make life insurance unavailable. Depending on your individual circumstances, certain carriers may be willing to consider coverage—even in cases that may initially seem challenging.
Here’s something many people may not know: we work with a carrier that may offer competitive rates to certain applicants with active prostate cancer that was diagnosed within 12 months of applying.
Our goal is to explore available coverage options regardless of the type of cancer you have been diagnosed with. Every case is unique, and all offers are subject to the carrier’s complete medical underwriting, eligibility requirements, and final approval.
Let us review your situation and help identify the carriers that may be the best fit for your specific circumstances.